Galenica Ltd (XSWX:GALE)

Half Year 2025 Galenica AG Earnings Call Transcript

Aug 7, 2025 / 12:00 PM GMT

Release Date Price: CHF85.55 (-0.29%)

Transcript

Key Points

Positve

Galenica Ltd (XSWX:GALE) reported a strong 5% growth in sales for the first half of 2025, indicating robust market performance.
The company achieved a clear increase in profitability and significant improvements in cash flow during the first half of the year.
Galenica Ltd (XSWX:GALE) expanded its pharmacy network by a net 5 locations, contributing to a 1.8% impact on sales growth.
The acquisition of Laborine Group is expected to enhance Galenica Ltd (XSWX:GALE)'s portfolio in the diagnostics sector, offering potential for long-term growth.
The company is on track with its medium-term guidance and has increased its EBIT outlook from 4-6% to 7-9% due to strong first-half performance and positive one-off effects.

Negative

The consumer healthcare market experienced flat growth of 0.5% in the OTC segment, indicating challenges in this area.
Galenica Ltd (XSWX:GALE) faced a decline in export sales by 12.6% due to high prior-year sales linked to regulatory adjustments in the EU.
The company's gross margin slightly decreased due to product mix changes and the impact of more expensive drugs.
There is ongoing price pressure in the laboratory market, with expected price reductions in 2026 and 2027, which could impact profitability.
The ERP system implementation at the Lausanne location led to challenges, although efficiencies are expected to improve in the second half of 2025.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GALE.S - Galenica AG
Half Year 2025 Galenica AG Earnings Call
Aug 07, 2025 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good Morning and welcome to our Q2 2025 earnings call. Today I'm joined by our CEO Robert Ganz, and our co-CEO interim CFO David Scher. Robert will kick us off with a business update before handing over to David to walk you through the financial developments of the quarter.

Finally, Robert will discuss our outlook. Both will be available for questions afterwards. As usual, this call is being recorded, and the live webcast, as well as the replay of the call will be available on our investor relations webpage later today. I will now hand it over to Robert, the flaws is yours.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.